AGM/EGMApr 28, 2026, 05:07 PM
HEPA to Vote on 8M Share Equity Plan Increase at June 17 AGM
AI Summary
Hepion Pharmaceuticals, Inc. announced its Annual Meeting of Stockholders on June 17, 2026, where key proposals include the election of five directors and the ratification of Grassi & Co. as the independent auditor. A significant proposal involves amending the 2023 Omnibus Equity Incentive Plan to increase the number of shares issuable from 200,000 to 8,000,000, which could lead to substantial dilution. The filing also detailed the director nominees and corporate governance practices.
Key Highlights
- Annual Meeting of Stockholders scheduled for June 17, 2026.
- Proposal to increase shares under 2023 Omnibus Equity Incentive Plan from 200,000 to 8,000,000.
- Election of five directors: Vincent LoPriore, Gary Stetz, Chase LoPriore, Michael Purcell, Sireesh Appajosyula.
- Ratification of Grassi & Co., CPAs, P.C. as independent auditor for fiscal year 2026.
- Audit fees for 2025 were $323,663 and for 2024 were $419,220.
- Record date for voting is April 28, 2026.
Price Impact
More from HEPA